Expanded Access of Unproven Drugs: Not the Final Word

NEJM Evid. 2024 Oct;3(10):EVIDe2400282. doi: 10.1056/EVIDe2400282. Epub 2024 Sep 24.

Authors

H Clifford Lane¹, Anthony S Fauci²

Affiliations

¹ Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
² School of Medicine and the McCourt School of Public Policy, Georgetown University, Washington, DC.

PMID: 39315872
DOI: 10.1056/EVIDe2400282

No abstract available

Publication types

Editorial
Comment

MeSH terms

Drug Approval / legislation & jurisprudence
Health Services Accessibility*
Humans
United States